Exicure XCUR
NASDAQ XCUR
$1.16 +0.04 (+3.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Exicure (XCUR) Non-Current Deffered Revenue (2016 - 2022)

Updated

Exicure (XCUR) reported Non-Current Deffered Revenue of $9.04 million for Q2 2022, down 10.1% from the prior quarter.

Analysis

Exicure (XCUR) Non-Current Deffered Revenue (2016 - 2022) Analysis & Trends

At the end of FY2021, Exicure posted Non-Current Deffered Revenue of $11.51 million.

  • Non-Current Deffered Revenue has a five-year compound annual growth rate of 61.9% (FY2016 to FY2021).
  • By year, Non-Current Deffered Revenue came in at $2.96 million in FY2019.
  • The Q2 2022 figure ranks as the lowest quarterly Non-Current Deffered Revenue since Q4 2019.
  • Per Business Quant data, the three quarters before Q2 2022 came in at $10.05 million (Q1 2022), $11.51 million (Q4 2021) and $16.93 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Exicure 7.14 Mn 7.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 9.04 Mn
Mar 31, 2022 10.05 Mn
Dec 31, 2021 11.51 Mn
Sep 30, 2021 16.93 Mn
Dec 31, 2019 2.96 Mn
Dec 31, 2016 1.03 Mn
API Access

Exicure Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=XCUR&period=max&api_key=YOUR_API_KEY